obesity

News

Novo Nordisk gets NICE okay for obesity drug Wegovy

Novo Nordisk's new obesity therapy Wegovy has been recommended for routine NHS use by UK cost-effectiveness watchdog NICE, but in a narrower group of patients than is covered by its MHRA-ap

News

Novo Nordisk moves to strengthen obesity efforts

After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position in the obesity space through a collaboration with EraCal Therapeutics.

News

Novo Nordisk nears EU approval of obesity drug Wegovy

Danish drugmaker Novo Nordisk is hoping to launch its once-weekly injectable treatment for obesity, Wegovy, in the EU next year after getting a green light from the EMA's human medicines co

News

Regeneron, AZ team up on drugs for obesity "superpower" gene

AstraZeneca has formed a partnership with Regeneron to investigate the potential of treating obesity using drugs directed at GPR75, a protective gene identified by scientists at the Regener

News

FDA ends 7-year obesity drug drought, clearing Novo Nordisk'...

Novo Nordisk is celebrating the FDA approval of its GLP-1 agonist semaglutide as a treatment for obesity, which it believes has the potential to redefine the market for weight-loss medicine

News

Novo Nordisk’s semaglutide effective against obesity in new ...

Novo Nordisk’s hopes of getting semaglutide approved for obesity management may have received a boost, with a new, large trial showing the drug was able to cut body weight significantly over the

Novo Nordisk gets NICE okay for obesity drug Wegovy

Novo Nordisk moves to strengthen obesity efforts

Novo Nordisk nears EU approval of obesity drug Wegovy

Regeneron, AZ team up on drugs for obesity "superpower" gene

FDA ends 7-year obesity drug drought, clearing Novo Nordisk'...

Novo Nordisk’s semaglutide effective against obesity in new ...

US pharma tariffs of up to 100% finalised by Trump

Using AI-driven synthetic personas to take your insights fur...

obesity

Editor's Picks